Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...

India, July 13 -- With Alexander Zverev being a Type 1 Diabetic and receiving special exemption from the stakeholders to use ...

Danish pharma major Novo Nordisk has launched 'Awiqli' in India, a once-weekly basal insulin injection for adults with ...

Why did Alexander Zverev take an injection during Wimbledon final? - The French Open champion has a medical exemption needs ...

Novo Nordisk has launched Awiqli, the world's first once-weekly basal insulin, in India for adults with Type 1 and Type 2 diabetes. The shift from daily to weekly injections could ease treatment ...

Awiqli, the world's first once-a-week basal insulin, has been launched in India, reducing insulin injections from 365 to 52 a ...

Alexander Zverev's appearance in the Wimbledon final was about more than his battle against defending champion Jannik Sinner.

Viking's latest program seeks to push the envelope in weight loss efficacy.

Danish pharma major Novo Nordisk on Thursday launched in India its once-weekly basal insulin injection, ‘Awiqli’ indicated for treatment of diabetes in adults. The company is introducing Awiqli in two ...

One injection a week instead of one every day. Danish drugmaker Novo Nordisk has launched Awiqli, or insulin icodec, in India-the world's first once-weekly bas ...

An insulin inhaler proved safe for treating children as young as 4 years old, improving satisfaction and reducing weight gain ...